Reuters logo
BRIEF-Celldex Therapeutics Q2 loss per share $0.23
2017年8月8日 / 晚上9点48分 / 3 个月前

BRIEF-Celldex Therapeutics Q2 loss per share $0.23

Aug 8 (Reuters) - Celldex Therapeutics Inc

* Celldex reports second quarter 2017 results

* Celldex Therapeutics - Q2 revenue $3.8 million versus $1.4 million

* Q2 loss per share $0.23

* Q2 revenue view $1 million -- Thomson Reuters I/B/E/S

* Q2 earnings per share view $-0.27 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below